Optimal effect-site concentration of remifentanil for preventing cough
Not Applicable
Recruiting
- Conditions
- Not Applicable
- Registration Number
- KCT0001563
- Lead Sponsor
- Ajou University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
American Society of Anesthesiology physical status 1 and 2 patients, aged 20-65 years, undergoing video-assisted thoracoscopic lung lobectomy requiring one lung ventilation
Exclusion Criteria
Patients with administration of an angiotensin-converting enzyme inhibitor, anticipated difficult airway, patient with gastroesophageal reflux or asthma, chronic obstructive disease and upper respiratory infection
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method effect-site concentration of remifentanil for preventing cough during emergence after general anesthesia using double lumen tube
- Secondary Outcome Measures
Name Time Method hemodynamic data during emergence from general anesthesia